A wearable bladder monitoring device is disclosed (1) comprising securing means (27, 29) for securing the device to a subject's (40) body; a phased array (11) of ultrasound transducers (10) having configurable output frequencies; a configurable phased array controller (13) adapted to control the phased array to direct ultrasound beams (30, 30′, 30″) into the subject's body under a plurality of discrete beam angles and to collect echo signals (31, 31′, 31″) of said ultrasound beams, wherein the phased array controller (13) is adapted to direct a set of ultrasound beams (30, 30′, 30″) into the subject's body for at least a subset of said discrete beam angles in response to a configuration instruction defining the respective output frequencies of the ultrasound beams in said set; and a device communication module (21) for communicating data pertaining to said echo signals to a remote device (5) to facilitate the remote processing of said data and to receive said configuration instruction from the remote device. Also disclosed is a wearable bladder monitoring system adapted to generate such a configuration instruction for the estimation of the degree of turbidity of urine contained in the monitored bladder with the wearable bladder monitoring device, as well as a computer-implemented method and computer program product for facilitating such urine turbidity estimation.

A system includes a processing circuit configured to receive signals corresponding ultrasound data, extract a blood flow waveform from the signals, the blood flow waveform corresponds to a single pulse of the signals, determine a curvature characteristic of the blood flow waveform based on a plurality of local curvature parameters, and identify a medical condition for the blood flow waveform using the blood flow waveform. Each of the plurality of local curvature parameters indicates a degree to which the blood flow waveform deviates from a straight line at a location on the blood flow waveform.

A device is provided for automatically assessing functional hemodynamic properties of a patient is provided, the device comprising: a housing; an ultrasound unit coupled to the housing and adapted for adducing ultrasonic waves into the patient at a vessel; a detector adapted to sense signals obtained as a result of adducing ultrasonic waves into the patient at the vessel and to record the; and a processor adapted for receiving the recorded signals as data and transforming the data for output at an interface. Other devices, systems, methods, and/or computer-readable media may be provided in relation to assessing functional hemodynamics of a patient.

Aspects of the technology described herein related to monitoring fetal heartbeat and uterine contraction signals. An ultrasound system may be configured to sweep a volume to collect ultrasound data, detect a fetal heartbeat and/or uterine contraction signal in the ultrasound data, and automatically steer an ultrasound beam to monitor the fetal heartbeat and/or uterine contraction signal. The ultrasound system may be further configured to determine a location where the fetal heartbeat and/or uterine contraction signal is detectable or detectable at a highest quality. The ultrasound system may include a wearable ultrasound device, such as an ultrasound patch coupled to a subject. The wearable ultrasound device may have a two-dimensional array of ultrasonic transducers capable of steering ultrasound beams in three dimensions.

The embodiments herein provide a system for calibration-free cuff-less evaluation of blood pressure. The system includes an ultrasound-based arterial compliance probes and a controller unit connected to the said probe. The ultrasound transducers are configured to measure the change in arterial dimensions, pulse wave velocity, and other character traits of an arterial segment over continuous cardiac cycle, which is then used to evaluate blood pressure parameters without any calibration procedure using dedicated mathematical models. The pressure sensor/force sensor/bio-potential transducers/accelerometric sensors are configured to measure a pressure acting on a skin surface at a measurement site, an internal arterial transmural pressure level, an applied pressure or a hold-down pressure on the skin surface or an arterial site, biopotential and/or plethysmograph signal, arterial vibrations acting on the measurement site as a function of the arterial pressure and the mechanical characteristics and/or a function of the applied/hold-down pressure and/or function of external factors.

A method of non-invasively monitoring the respiration of a patient comprises: transmitting ultrasound into the body toward an internal structure of the patient's body, the internal structure being one of the liver, the spleen or a kidney; selecting a depth range; measuring the phase of ultrasound echo signals from the internal structure at multiple points along the depth range for at least a first and a second echo signal, the first and second echo signals being received at different times; detecting the motion of the internal structure within the patient's abdomen by reference to differences in the measured phase between the first and the second echo signals; and thereby monitoring the respiration of the patient by associating movement of the internal structure with movement caused by respiration.

A device is provided for automatically assessing functional hemodynamic properties of a patient is provided, the device comprising: a housing; an ultrasound unit coupled to the housing and adapted for adducing ultrasonic waves into the patient at a vessel; a detector adapted to sense signals obtained as a result of adducing ultrasonic waves into the patient at the vessel and to record the; and a processor adapted for receiving the recorded signals as data and transforming the data for output at an interface. Other devices, systems, methods, and/or computer-readable media may be provided in relation to assessing functional hemodynamics of a patient.

The invention provides an ultrasound system including an ultrasound transducer array and a processor. The ultrasound transducer array comprises a plurality of transducer elements adapted to conform with a subjects body. Further, at least two ultrasound transducer elements of the plurality of transducer elements are adapted to acquire a plurality of ultrasound signals from a region of interest at different orientations relative to said region of interest. The processor is adapted to receive ultrasound signals acquired by the ultrasound transducer array. The processor is further adapted to partition the plurality of ultrasound signals according to a signal depth and, for each ultrasound signal partition, calculate a Doppler power. For each ultrasound signal, the processor identifies a depth of a fetal heartbeat based on the Doppler power of each ultrasound signal partition and identifies a fetal heart region based on the identified fetal heartbeat and a location of the at least two ultrasound transducers.

An ultrasound imaging probe including a handle configured for handheld use; a support structure disposed within the handle and comprising a thermally-conductive material, the support structure further comprising a coupling surface and an external surface, the coupling surface disposed at a distal portion of the support structure; a continuous material layer coupled to the support structure, such that the continuous material layer is disposed on the coupling surface and the external surface, the continuous material layer thereby providing a heat transmission path between the coupling surface and the external surface; and an ultrasound sensor coupled to the support structure at the coupling surface and directly in contact with the continuous material layer at the coupling surface, such that heat from the ultrasound sensor is transmitted away to the support structure via the heat transmission path of the continuous material layer.

Systems and methods for treating skin and subcutaneous tissue with energy such as ultrasound energy are disclosed. In various embodiments, ultrasound energy is applied at a region of interest to affect tissue by cutting, ablating, micro-ablating, coagulating, or otherwise affecting the subcutaneous tissue to conduct numerous procedures that are traditionally done invasively in a non-invasive manner. Lifting sagging tissue on a face, neck, and/or body are described. Treatment with heat is provided in several embodiments.